We are live on ! Find out more
PMC

PharMerica Corporation
PMC

Delisted

PMC was delisted on the 7th of December, 2017.

166 hedge funds and large institutions have $736M invested in PharMerica Corporation in 2016 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 59 increasing their positions, 55 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

7% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 55

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

5% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 20

3% less funds holding

Funds holding: 172166 (-6)

12% less capital invested

Capital invested by funds: $832M → $736M (-$95.9M)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $3K

Holders
166
Holders Change
-6
Holders Change %
-3.49%
% of All Funds
4.15%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
19
Increased
59
Reduced
55
Closed
20
Calls
Puts
$3K
Net Calls
-$3K
Net Calls Change
+$3.14M
Name Holding Trade Value Shares
Change
Change in
Stake
DC
176
Deere & Company
Illinois
-$218K -7,756 Closed
SG Americas Securities
177
SG Americas Securities
New York
-$154K -5,478 Closed
GP
178
GLG Partners
United Kingdom
-$143K -5,090 Closed
FQ
179
First Quadrant
California
-$18K -651 Closed
FNYS
180
First New York Securities
New York
-$14K -500 Closed
PG
181
PEAK6 Group
Illinois
-$13K -456 Closed

PMC Hedge Fund Activity: Q4 2016 in Review

166 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in PharMerica Corporation (PMC) for Q4 2016, worth a combined $736M — down 12% from $832M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of PMC and 19 opened new positions — a net loss of 1 holder — while 55 trimmed existing stakes and 59 added.

The largest buyer was Boston Partners, adding an estimated $23.1M. The largest seller was Balyasny Asset Management, cutting an estimated $16.2M.

  • 166 institutional investors held PharMerica Corporation (PMC) as of Q4 2016, down from 172 in Q3 2016.
  • Funds reported $736M of PharMerica Corporation stock for Q4 2016, down 12% quarter-over-quarter.
  • 19 funds opened new PharMerica Corporation positions in Q4 2016 and 20 closed out, a net change of -1 holder.
  • The largest PharMerica Corporation buyer in Q4 2016 was Boston Partners, an estimated $23.1M added.
  • The largest PharMerica Corporation seller in Q4 2016 was Balyasny Asset Management, an estimated $16.2M sold.

Based on aggregated 13F filings for Q4 2016.